Thats why its important to discuss your weight loss goal, personal and family medical history, and any side effects with your provider
&srotate=0)
When patients use both treatments concurrently, several precautions are warranted : Injection site management : Rotate sites systematically and avoid administering both injections in the same anatomical area on the same day Gastrointestinal monitoring : Tirzepatide's GI effects may be misattributed to lipotropic injections, potentially leading to inappropriate dose adjustments Hydration emphasis : Ensure adequate fluid intake given tirzepatide's potential to cause dehydration through GI effects Medication adjustments : Consider reducing doses of insulin or sulfonylureas when initiating tirzepatide to mitigate hypoglycemia risk Realistic expectations : Counsel patients that weight loss benefits derive primarily from tirzepatide's pharmacological action Cost considerations : Lipotropic injections represent additional out-of-pocket expense without proven incremental benefit Patients should seek immediate medical attention for severe or persistent abdominal pain (possible pancreatitis), right upper quadrant pain with fever or jaundice (gallbladder disease), signs of allergic reaction, persistent vomiting leading to dehydration, or symptomatic hypoglycemia if on insulin/sulfonylureas

Novo and Hims had a partnership in 2025 allowing the telehealth company to offer injectable Wegovy, but the two companies walked away with Novo saying Hims had wrongfully marketed versions of its medicine
Weight loss is not solely dependent on willpower, as there are biological factors that affect metabolism, hunger, and weight that are beyond your control